Neuphoria Therapeutics Inc (NEUP)

$4.17 -0.03 (-0.71%)
Market Cap 22.59M
Revenue (ttm) 15.65M
Net Income (ttm) -370,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2.36%
Debt to Equity Ratio 0.00
Volume 33,900
Avg Vol 128,848
Day's Range N/A - N/A
Shares Out 5.38M
Stochastic %K 63%
Beta 0.51
Analysts Sell
Price Target $13.50

Company Profile

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7 for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 439 5551
Address:
100 Summit Drive, Burlington, United States
I_am_retail_investor
I_am_retail_investor Jan. 9 at 10:48 PM
$NEUP - JPMorgan Healthcare next week, great period for $NEUP to make a positive announcement
0 · Reply
I_am_retail_investor
I_am_retail_investor Jan. 9 at 5:07 PM
$NEUP - feels like something is happening via the chart .. anyone’s magic eight ball guess!
1 · Reply
Quido22
Quido22 Jan. 8 at 2:10 PM
$NEUP BUYOUT OR MERGER INCOMING. Mr. Papapetropoulos will serve as the interim CEO to the Company for up to twelve months to support the execution of the Company’s contemplated strategic transaction and ensure a seamless transition"
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Jan. 8 at 1:29 PM
$NEUP I Wasn't Expecting This, CEO Resigned ❓ Buyout Coming ❓ https://ir.neuphoriatx.com/node/11436/html
0 · Reply
stabbed
stabbed Jan. 7 at 8:04 PM
$NEUP - back in! Let's Go!
0 · Reply
Redposition
Redposition Jan. 7 at 6:50 PM
$NEUP Why down 🤔
0 · Reply
Quido22
Quido22 Jan. 6 at 2:44 PM
$NEUP
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Jan. 5 at 9:47 PM
$NEUP https://clinicaltrials.gov/study/NCT06721156?tab=history&a=33#version-content-panel
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Jan. 5 at 9:37 PM
$NEUP https://www.merck.com/news/merck-showcases-data-for-alzheimers-disease-candidates-mk-2214-and-mk-1167-at-ctad-2025/
1 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Jan. 5 at 1:03 AM
$NEUP I'm expecting a reply to this tomorrow or within days by the company.
0 · Reply
Latest News on NEUP
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees

Dec 8, 2025, 8:00 AM EST - 5 weeks ago

Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees

Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium

Dec 4, 2025, 8:00 AM EST - 5 weeks ago

Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions

Dec 1, 2025, 8:00 AM EST - 6 weeks ago

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions

Neuphoria Therapeutics Inc. Sends Letter to Stockholders

Nov 24, 2025, 8:00 AM EST - 7 weeks ago

Neuphoria Therapeutics Inc. Sends Letter to Stockholders

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value

Nov 11, 2025, 7:00 AM EST - 2 months ago

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

Oct 27, 2025, 4:29 PM EDT - 2 months ago

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Oct 21, 2025, 8:16 AM EDT - 3 months ago

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

CTXR PCAR

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder

Oct 20, 2025, 4:15 PM EDT - 3 months ago

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder

Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

Sep 29, 2025, 4:54 PM EDT - 3 months ago

Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates

Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)

Sep 4, 2025, 7:00 AM EDT - 4 months ago

Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)

Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 28, 2025, 4:05 PM EDT - 4 months ago

Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting

May 27, 2025, 4:10 PM EDT - 8 months ago

Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting

Neuphoria Provides First Quarter 2025 Business Updates

May 20, 2025, 4:22 PM EDT - 8 months ago

Neuphoria Provides First Quarter 2025 Business Updates

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Apr 15, 2025, 8:00 AM EDT - 9 months ago

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Mar 3, 2025, 7:30 AM EST - 11 months ago

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Feb 12, 2025, 7:00 AM EST - 1 year ago

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

Dec 23, 2024, 4:49 PM EST - 1 year ago

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

I_am_retail_investor
I_am_retail_investor Jan. 9 at 10:48 PM
$NEUP - JPMorgan Healthcare next week, great period for $NEUP to make a positive announcement
0 · Reply
I_am_retail_investor
I_am_retail_investor Jan. 9 at 5:07 PM
$NEUP - feels like something is happening via the chart .. anyone’s magic eight ball guess!
1 · Reply
Quido22
Quido22 Jan. 8 at 2:10 PM
$NEUP BUYOUT OR MERGER INCOMING. Mr. Papapetropoulos will serve as the interim CEO to the Company for up to twelve months to support the execution of the Company’s contemplated strategic transaction and ensure a seamless transition"
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Jan. 8 at 1:29 PM
$NEUP I Wasn't Expecting This, CEO Resigned ❓ Buyout Coming ❓ https://ir.neuphoriatx.com/node/11436/html
0 · Reply
stabbed
stabbed Jan. 7 at 8:04 PM
$NEUP - back in! Let's Go!
0 · Reply
Redposition
Redposition Jan. 7 at 6:50 PM
$NEUP Why down 🤔
0 · Reply
Quido22
Quido22 Jan. 6 at 2:44 PM
$NEUP
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Jan. 5 at 9:47 PM
$NEUP https://clinicaltrials.gov/study/NCT06721156?tab=history&a=33#version-content-panel
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Jan. 5 at 9:37 PM
$NEUP https://www.merck.com/news/merck-showcases-data-for-alzheimers-disease-candidates-mk-2214-and-mk-1167-at-ctad-2025/
1 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Jan. 5 at 1:03 AM
$NEUP I'm expecting a reply to this tomorrow or within days by the company.
0 · Reply
joe77w
joe77w Jan. 4 at 5:52 PM
$NEUP Merck partnership return could be a multiple of current depressed pps imo, if ph2 succesful https://www.msn.com/en-us/money/savingandinvesting/neuphoria-therapeutics-to-receive-15m-milestone-payment-from-merck/ar-AA1yTlyG?ocid=finance-verthp-feeds&apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1
0 · Reply
joe77w
joe77w Jan. 3 at 10:02 AM
$NEUP pps should be 10 USD not lower, cash alone worth current market cap!!!
0 · Reply
joe77w
joe77w Jan. 3 at 7:59 AM
$NEUP excellent news! Neup worth 10 USD at least imo, IP alone worth much more than market cap, then Add the cash position worth at least the market cap plus NASDAQ LISTING and we get a pps well above 10 USD, Hope to see PPS close the gap with valuation
0 · Reply
CANITBTHISEZTOMAKEMONEY
CANITBTHISEZTOMAKEMONEY Jan. 3 at 1:09 AM
$NEUP OH, I noticed it. Licking my chops 👅 Which IP are they after? LYNX1 knows something, which IP are they after❓
0 · Reply
frontiere
frontiere Jan. 2 at 8:35 PM
$NEUP Neuphoria ex $BNOX Bionomics ref=$3.89 — Long again — nobody noticed the new proposal 2025-12-26 from Lynx1 Weston Nichols to buy some IP assets from NEUP for cash or similar stock consideration? 👍 As the old offer of the $4.75 cash takeover got spurned by NEUP. Bullish! 13D https://www.sec.gov/Archives/edgar/data/1191070/000090514825004208/xslSCHEDULE_13D_X01/primary_doc.xml Prior see my long history of posts on name.
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 1 at 5:00 AM
$NEUP
0 · Reply
KingZack25
KingZack25 Dec. 30 at 8:14 PM
$NEUP Lynx wont give up. Clearly finding some value in this company
0 · Reply
I_am_retail_investor
I_am_retail_investor Dec. 22 at 11:50 PM
$NEUP - merger is more likely than buyout, but hoping for the BO
1 · Reply
LilySanders
LilySanders Dec. 21 at 3:48 PM
$NEUP microcap hugging the floor, first higher low plus sustained buying is the only sign the tide really turned
1 · Reply
guidoschini
guidoschini Dec. 19 at 12:58 PM
$NEUP NEUP is a scam. only down
0 · Reply
JohnTrack
JohnTrack Dec. 18 at 11:34 PM
$NEUP eyes on this trendline...
1 · Reply
JohnTrack
JohnTrack Dec. 18 at 9:24 PM
$NEUP press flare just now!!! https://www.rapidticker.com/news/neup-sec-filing-be9723
0 · Reply